Acute Respiratory Distress Syndrome (ARDS). Yale Medicine. https://www.yalemedicine.org/conditions/ards/. Published October 29, 2020. Accessed November 24, 2020.
Ahmed W, Vidal-Alaball J, Downing J, Seguí FL. COVID-19 and the 5G conspiracy theory: Social network analysis of twitter data. Journal of Medical Internet Research. 2020;22(5):e19458. doi:10.2196/19458
American Association of Poison Control Centers. Hand Sanitizer. https://aapcc.org/track/hand-sanitizer. Accessed November 24, 2020.
Andersen, K.G., Rambaut, A., Lipkin, W.I. et al. The proximal origin of SARS-CoV-2. Nat Med 26, 450–452 (2020). https://doi.org/10.1038/s41591-020-0820-9
Asadi S, Cappa CD, Barreda S, Wexler AS, Bouvier NM, Ristenpart WD. Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities. Scientific Reports. 2020;10(1). doi:10.1038/s41598-020-72798-7.
Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for Camel-to-Human Transmission of MERS Coronavirus. New England Journal of Medicine. 2014;371(14):1359-1360. doi:10.1056/nejmc1409847
Beigel JH, Tomashek KM, Dodd LE, et al (2020) Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med 383:1813–1826. https://doi.org/10.1056/nejmoa2007764
Boyd A. The Star: Human testing of Pfizer’s experimental COVID-19 vaccine candidate has now wrapped up, which will shift focus to Health Canada, who will make the decision whether to approve. CANADA As Pfizer finishes COVID-19 vaccine testing, Elliott reveals how many doses Ottawa and Ontario are expecting. Published November 18, 2020. Accessed November 19, 2020. https://www.thestar.com/news/canada/2020/11/18/as-pfizer-finishes-covid-19-vaccine-testing-the-spotlight-shifts-to-health-canada.html
Bruns A, Harrington S, Hurcombe E. ‘Corona? 5G? or both?’: the dynamics of COVID-19/5G conspiracy theories on Facebook. Media International Australia. 2020;177(1):12-29. doi:10.1177/1329878X20946113
Burki T. The origin of SARS-CoV-2. The Lancet Infectious diseases. 2020;20(9):1018-1019. doi:10.1016/S1473-3099(20)30641-1
Canada PHAof. Epidemiological summary of COVID-19 cases in Canada. Canada.ca. https://health-infobase.canada.ca/covid-19/epidemiological-summary-covid-19-cases.html. Published August 7, 2020. Accessed November 20, 2020.
Canadian Mental Health Association. Canadian Mental Health Association: Are You in Crisis? ontario.cmha.ca. Published 2020. Accessed November 17, 2020. https://ontario.cmha.ca/documents/are-you-in-crisis/
Centers for Disease Control and Prevention. Coronavirus. Published February 15, 2020. Accessed November 19, 2020. https://www.cdc.gov/coronavirus/types.html
Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Disease (NCIRD). Variant Influenza Viruses: Background and CDC Risk Assessment and Reporting | CDC. cdc.gov. Published November 12, 2016. Accessed November 19, 2020. https://www.cdc.gov/flu/swineflu/variant.htm
Communications Research Centre Canada. Communications Research Centre Canada: What is 5G? . ic.gc.ca. Published July 20, 2017. Accessed November 19, 2020. https://www.ic.gc.ca/eic/site/069.nsf/eng/00077.html
Communications Research Centre Canada. Radiofrequency Energy and Safety – Spectrum management and telecommunications. ic.gc.ca. Published May 13, 2020. Accessed November 19, 2020. http://www.ic.gc.ca/eic/site/smt-gst.nsF/eng/sf11467.html
Contrera K. Coronaviruses Have Been Around For Centuries: What Differentiates COVID-19? Consult QD. Published May 18, 2020. Accessed November 19, 2020. https://consultqd.clevelandclinic.org/coronaviruses-have-been-around-for-centuries-what-differentiates-2019-ncov/
Coronavirus disease (COVID-19): Prevention and risks – Canada.ca. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html?&utm_campaign=gc-hc-sc-coronavirus2021-ao-2021-0005-10020125402&utm_medium=search&utm_source=google-ads-107800103024&utm_content=text-en-434525470206&utm_term=coronavirus how it spreads. Accessed November 21, 2020.
Counterfeit Respirators / Misrepresentation of NIOSH-Approval. Centers for Disease Control and Prevention. https://www.cdc.gov/niosh/npptl/usernotices/counterfeitResp.html. Published November 5, 2020. Accessed November 24, 2020.
COVID Alert: Canada’s COVID-19 exposure notification app. Canada.ca. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/covid-alert-app.html. Published July 31, 2020. Accessed November 24, 2020.
COVID-19 (coronavirus): Long-term effects. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351. Published November 17, 2020. Accessed November 20, 2020.
COVID-19 Map. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed November 26, 2020.
COVID-19: Considerations for Wearing Masks. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html. Published November 12, 2020. Accessed November 24, 2020.
Create a social circle during COVID-19. ontario.ca. https://www.ontario.ca/page/create-social-circle-during-covid-19. Published June 12, 2020. Accessed November 24, 2020.
Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Microbiology. 2019; 17: 181-192.
Diamond M, Peniston Feliciano HL, Sanghavi D, et al. Acute Respiratory Distress Syndrome. [Updated 2020 Nov 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436002/
Douglas KM, Uscinski JE, Sutton RM, et al. Understanding Conspiracy Theories. Political Psychology. 2019;40(S1):3-35. doi:10.1111/pops.12568
Forbes N, Patel M, Rieder M, Salvadori M (2020) Ad-hoc COVID-19 Clinical Pharmacology Task Group: Statement on remdesivir. In: canada.ca. https://www.canada.ca/en/public-health/corporate/mandate/about-agency/external-advisory-bodies/list/covid-19-clinical-pharmacology-task-group/statement-remdesivir.html. Accessed 27 Nov 2020
Gilead Sciences (2020) Gilead Sciences’ Response to COVID-19. https://www.gilead.com/purpose/advancing-global-health/covid-19. Accessed 27 Nov 2020
Gilead Sciences (2020) Gilead Sciences Statement on The World Health Organization’s Updated Veklury® (Remdesivir) COVID-19 Treatment Guidelines. https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-updated-veklury-covid19-treatment-guidelines. Accessed 27 Nov 2020
Government of Canada. COVID-19: Non-medical masks and face coverings – Canada.ca. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks/about-non-medical-masks-face-coverings.html. Published November 3, 2020. Accessed November 24, 2020.
Government of Ontario. COVID-19 in Ontario: COVID-19 test and testing location information . ontario.ca. Published 2020. Accessed November 16, 2020. https://covid-19.ontario.ca/covid-19-test-and-testing-location-information
Government of Ontario. COVID-19 in Ontario: COVID-19 testing locations. ontario.ca. Published 2020. Accessed November 16, 2020. https://covid-19.ontario.ca/assessment-centre-locations
Grein J, Ohmagari N, Shin D, et al (2020) Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med 382:2327–2336. https://doi.org/10.1056/nejmoa2007016
Harvard Health Publishing (2020) Treatments for COVID-19 – What helps, what doesn’t, and what’s in the pipeline. https://www.health.harvard.edu/diseases-and-conditions/treatments-for-covid-19. Accessed 27 Nov 2020
Health Canada (2020) Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician. – Recalls and safety alerts. In: healthycanadians.gc.ca. https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72885a-eng.php. Accessed 27 Nov 2020
How to Safely Wear and Take Off a Cloth Face Covering. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-to-wear-cloth-face-coverings.html. Published September 3, 2020. Accessed November 24, 2020.
Jorge A (2020) Hydroxychloroquine in the prevention of COVID-19 mortality. Lancet Rheumatol 1–2. https://doi.org/10.1016/s2665-9913(20)30390-8
Legionnaires Disease and Pontiac Fever. Centers for Disease Control and Prevention. https://www.cdc.gov/legionella/. Published April 30, 2018. Accessed November 24, 2020.
Long-Term Effects of COVID-19. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html. Published November 13, 2020. Accessed November 24, 2020.
Luo L, Liu D, Liao X, et al. Modes of contact and risk of transmission in COVID-19 among close contacts. 2020. doi:10.1101/2020.03.24.20042606
Maragakis LL. Coronavirus, Social and Physical Distancing and Self-Quarantine. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/coronavirus-social-distancing-and-self-quarantine. Published July 15, 2020. Accessed November 24, 2020.
Moderna’s Work on a COVID-19 Vaccine Candidate. Moderna, Inc. https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19. Published November 16, 1970. Accessed November 26, 2020.
National Center for Immunization and Respiratory Diseases (NCIRD) Division of Viral Diseases. CDC: Coronavirus Disease 2019 (COVID-19): Testing for COVID-19. cdc.gov. Published December 21, 2020. Accessed November 16, 2020. https://www.cdc.gov/coronavirus/2019-ncov/testing/diagnostic-testing.html#who-should-get-tested
National Center for Immunization and Respiratory Diseases (NCIRD) Division of Viral Diseases. CDC: Coronavirus Disease 2019 (COVID-19): Health Equity Considerations and Racial and Ethnic Minority Groups. cdc.gov. Published July 24, 2020. Accessed November 14, 2020. https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.html
National Foundation for Infectious Diseases. Coronaviruses. Published November 12, 2020. Accessed November 19, 2020. https://www.nfid.org/infectious-diseases/coronaviruses/
National Foundation for Infectious Diseases. Frequently Asked Questions About Novel Coronavirus (COVID-19). Published November 18, 2020. Accessed November 19, 2020. https://www.nfid.org/infectious-diseases/frequently-asked-questions-about-novel-coronavirus-2019-ncov/
Newman RA, Sastry JK, Arav-Boger R, et al (2020) Antiviral Effects of Oleandrin . J Exp Pharmacol 12:503–515
Nutrition and Immunity. The Nutrition Source. https://www.hsph.harvard.edu/nutritionsource/nutrition-and-immunity/. Published November 12, 2020. Accessed November 24, 2020.
Our COVID-19 Vaccine Study – What’s Next? Pfizer. https://www.pfizer.com/news/hot-topics/our_covid_19_vaccine_study_what_s_next. Published November 20, 2020. Accessed November 26, 2020.
Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. E Clinical Medicine. 2020;23:100404. doi:10.1016/j.eclinm.2020.100404
Pirbright Institute. Our major stakeholders. pirbright.ac.uk. Published May 7, 2020. Accessed November 19, 2020. https://www.pirbright.ac.uk/partnerships/our-major-stakeholders
Pirbright Institute. Pirbright’s livestock coronavirus research – your questions answered. pirbright.ac.uk. Published January 24, 2020. Accessed November 19, 2020. https://www.pirbright.ac.uk/news/2020/01/pirbright%E2%80%99s-livestock-coronavirus-research-%E2%80%93-your-questions-answered
Plante K, Plante J, Fernandez D, et al (2020) Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin. bioRxiv Prepr Serv Biol 2020.07.15.203489. https://doi.org/10.1101/2020.07.15.203489
Schwarcz J (2020) Planting a Toxic Oleander Seed . In: McGill Off. Sci. Soc. https://www.mcgill.ca/oss/article/covid-19-pseudoscience/planting-toxic-seed-oleander. Accessed 27 Nov 2020
Serious Adverse Health Events, Including Death, Associated with Ingesting Alcohol-Based Hand Sanitizers Containing Methanol – Arizona and New Mexico, May–June 2020. Centers for Disease Control and prevention. https://www.cdc.gov/mmwr/volumes/69/wr/mm6932e1.htm. Published August 13, 2020. Accessed November 24, 2020.
Show Me the Science – When & How to Use Hand Sanitizer in Community Settings. Centers for Disease Control and Prevention. https://www.cdc.gov/handwashing/show-me-the-science-hand-sanitizer.html. Published September 10, 2020. Accessed November 24, 2020.
Statistics Canada. Canadian Economic Dashboard and COVID-19. canada.ca. Published November 13, 2020. Accessed November 17, 2020. https://www150.statcan.gc.ca/n1/pub/71-607-x/71-607-x2020009-eng.htm
Student Wellness Services. Student Wellness: COVID-19 FAQs for Student Wellness Services. wellness.uoguelph.ca. Published November 30, 2020. Accessed November 16, 2020. https://wellness.uoguelph.ca/covid-19-faqs-student-wellness-services
Surkova E, Vladyslav, Drobniewski F. The Lancet Respiratory Medicine. 2020; 200: 30453-30457. doi:https://doi.org/10.1016/S2213-2600(20)30453-7
Vulnerable populations and COVID-19 – Canada.ca. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/vulnerable-populations-covid-19.html. Accessed November 24, 2020.
U.S. Food & Drug Administration (2020) Frequently Asked Questions for Veklury (remdesivir).
U.S. Food & Drug Administration (2020) Frequently Asked Questions on the Revocation of the Emergency Use Authorization for Hydroxychloroquine Sulfate and Chloroquine Phosphate.
W. Joost Wiersinga MD. Coronavirus Disease 2019 (COVID-19)-Epidemiology, Diagnosis, and Treatment. JAMA. Published August 25, 2020. Accessed November 19, 2020. https://jamanetwork.com/journals/jama/article-abstract/2768391
Wang N, Li S-Y, Yang X-L, et al. Serological evidence of bat SARS-related coronavirus infection in humans, China. Virologica Sinica. 2018;33(1):1-11. doi:10.1007/s12250-017-4124-2
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA – J Am Med Assoc. 2020;324(8):782-793. doi:10.1001/jama.2020.12839
Wolinsky H. Tagging products and people. Despite much controversy, radiofrequency identification chips have great potential in healthcare. EMBO Reports. 2006;7(10):965-968. doi:10.1038/sj.embor.7400810
World Health Organization (2020) Coronavirus disease (COVID-19): Hydroxychloroquine. In: who.int. https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-hydroxychloroquine. Accessed 27 Nov 2020
World Health Organization (2020) WHO recommends against the use of remdesivir in COVID-19 patients. In: who.int. https://www.who.int/news-room/feature-stories/detail/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients. Accessed 27 Nov 2020
Wuhan Institute of Virology CA of S. Wuhan Institute of Virology: About WIV. english.whiov.cas.cn. Published 2016. Accessed November 19, 2020. http://english.whiov.cas.cn/About_Us2016/Brief_Introduction2016/
Young B, Tan TT, Leo YS (2020) The place for remdesivir in COVID-19 treatment. Lancet Infect Dis 0: https://doi.org/10.1016/S1473-3099(20)30911-7
Zuckerman JN. The importance of injecting vaccines into muscle. British Medical Journal. 2000;321(7271):1237-1238. doi:10.1136/bmj.321.7271.1237